The Brexit picture is getting muddier by the day. Everything from a quick process to another referendum to nullify the first one have been proposed. The only certainty is that no one knows how this is all going to play out. If you look at the markets, you’d think the Brexit vote was going to…
DetailsWithin minutes, global markets lost $2 trillion. Indexes buckled under the strain of Britain’s vote to leave the European Union (EU). The pound tumbled to its lowest point in 30 years. The Dow Jones Industrial Average plummeted 600 points. The FTSE 100 Index fell to a 2008 low. Gold surged to $1,358 an ounce. Banking…
Details“This is a vote that changes everything.” That’s what the Financial Times wrote following the Brexit referendum. The market agrees. You don’t need a rundown. However, most everyone is missing one crucial aspect to all this. And they’re missing the opportunities created by it too.
DetailsJust the other day, we spoke about Exact Sciences (EXAS), and the reasons for which the stock moved aggressively higher. While we made no recommendation to buy the stock at such an elevated price, we were careful to point out that it was another example of Wall Street hyping a stock to unrealistic prices because…
DetailsEarlier this week Tesla (TSLA) announced it was going to acquire SolarCity (SCTY). Elon Musk, the chairman of SolarCity and CEO of Tesla, called it a “no brainer.” He may have been more right than he realizes.
DetailsThe biotech sector has had a rough time for the past year. The NASDAQ Biotech Index (IBB) fell 37% from a high of 401 in July 2015 to a low of 250. All as presidential candidates have bashed drug price gouging, and fears of an over-inflated bubble knocked many related stocks off their pedestals. The…
DetailsIn September 1992, George Soros “broke the bank of England,” and raked in more than a billion dollars in a single day. All he did was short the pound. Nowadays, he’s warning that a UK exit from the EU could unleash a similar drop, perhaps by 15% to 20%. “The Brexit crash will make all…
DetailsToo hot to swim. That’s how you’re editor described the heatwave crossing the southwest. It hit 122 degrees this weekend in Scottsdale, Arizona. Even the “dry heat” is still 122 degrees. It was pretty bad. No one did anything. No going out. No hiking. No anything. However, there was a silver lining. I got a…
DetailsColorectal cancer is the third most common cancer diagnosis in the United States. The American Cancer Society estimates it’ll see 95,270 cases on colon cancer, 39,220 new cases of rectal cancer… and as many as 49,190 deaths this year alone. Fortunately, that death rate has been falling in both men and women for years because…
DetailsI was talking to a colleague late on Wednesday night. Now, he’s not a “gold guy” by any stretch. But for one simple, important, and undeniable reason quickly becoming one. Your editor gave him two bits of advice from personal experience. First, I showed this chart on gold stocks. Second, I told him about this…
DetailsIn late 2014, shares of Pain Therapeutics plunged after Pfizer ended an agreement to help it develop and market the Remoxy pain drug along with Durect Corporation. The stock was left for dead, ignored. But things are rapidly improving. So much so, the stock rocketed from our recommended entry price of $1.83 in the July…
DetailsThere’s a new bull market emerging. It’s an idea that would have seemed absurd a few years ago. Yet, while stocks are stuck in a multi-year holding pattern, it churns higher month after month. It’s beating gold. Trouncing silver. And outpacing probably 98% of all stocks in the market. And thanks to a unique and…
Details